Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Mulhall

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Impotence Research|September 26, 2000
Inhibition of Peyronie's plaque fibroblast proliferation by biologic agentsM S Anderson, T V Shankey, T Lubrano, et al.
International Journal of Impotence Research|February 13, 2004
Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's diseaseJ P Mulhall, B Nicholson, S Pierpaoli, et al.
The Journal of Urology|March 1, 1994
Impotence and chronic renal failure: a study of the hemodynamic pathophysiologyJ M Kaufman, D G Hatzichristou, J P Mulhall, et al.
Urology|January 1, 1997
Presence of mature sperm in testicular parenchyma of men with nonobstructive azoospermia: prevalence and predictive factorsJ P Mulhall, C M Burgess, D Cunningham, et al.
Human Reproduction (Oxford, England)|March 1, 1997
Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis: fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injectionJ P Mulhall, R Reijo, R Alagappan, et al.
International Journal of Impotence Research|February 20, 2004
Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse modelJ P Mulhall, D J Martin, T Lubrano, et al.
Reviews in Urology|September 21, 2006
Therapeutic strategies for localized prostate cancer I: surgery, ultrasound, adjuvant and neoadjuvant therapyM I Resnick, E D Crawford, M E Gleave, et al.
International Journal of Clinical Practice|August 25, 2015
Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trialsC Vlachopoulos, M Oelke, M Maggi, et al.
The Journal of Urology|September 24, 1999
The causes of patient dropout from penile self-injection therapy for impotenceJ P Mulhall, A E Jahoda, M Cairney, et al.
The Journal of Urology|October 23, 1997
Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapyJ P Mulhall, M Daller, A M Traish, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Impotence Research|September 26, 2000
Inhibition of Peyronie's plaque fibroblast proliferation by biologic agentsM S Anderson, T V Shankey, T Lubrano, et al.
International Journal of Impotence Research|February 13, 2004
Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's diseaseJ P Mulhall, B Nicholson, S Pierpaoli, et al.
The Journal of Urology|March 1, 1994
Impotence and chronic renal failure: a study of the hemodynamic pathophysiologyJ M Kaufman, D G Hatzichristou, J P Mulhall, et al.
Urology|January 1, 1997
Presence of mature sperm in testicular parenchyma of men with nonobstructive azoospermia: prevalence and predictive factorsJ P Mulhall, C M Burgess, D Cunningham, et al.
Human Reproduction (Oxford, England)|March 1, 1997
Azoospermic men with deletion of the DAZ gene cluster are capable of completing spermatogenesis: fertilization, normal embryonic development and pregnancy occur when retrieved testicular spermatozoa are used for intracytoplasmic sperm injectionJ P Mulhall, R Reijo, R Alagappan, et al.
International Journal of Impotence Research|February 20, 2004
Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse modelJ P Mulhall, D J Martin, T Lubrano, et al.
Reviews in Urology|September 21, 2006
Therapeutic strategies for localized prostate cancer I: surgery, ultrasound, adjuvant and neoadjuvant therapyM I Resnick, E D Crawford, M E Gleave, et al.
International Journal of Clinical Practice|August 25, 2015
Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trialsC Vlachopoulos, M Oelke, M Maggi, et al.
The Journal of Urology|September 24, 1999
The causes of patient dropout from penile self-injection therapy for impotenceJ P Mulhall, A E Jahoda, M Cairney, et al.
The Journal of Urology|October 23, 1997
Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapyJ P Mulhall, M Daller, A M Traish, et al.
Pageof 5